Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach The Euro Heart Survey on Atrial Fibrillation

被引:5221
|
作者
Lip, Gregory Y. H. [1 ]
Nieuwlaat, Robby [2 ]
Pisters, Ron [2 ]
Lane, Deirdre A. [1 ]
Crijns, Harry J. G. M. [2 ]
机构
[1] Univ Birmingham, Ctr Cardiovasc Sci, City Hosp, Birmingham B18 7QH, W Midlands, England
[2] Maastricht Univ, Dept Cardiol, Med Ctr, Maastricht, Netherlands
关键词
LOW-DOSE ASPIRIN; ISCHEMIC-STROKE; ANTITHROMBOTIC TREATMENT; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; PREVENTION; THERAPY; GENDER; ANTICOAGULATION; PROGRESSION;
D O I
10.1378/chest.09-1584
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Contemporary clinical risk stratification schemata for predicting stroke and thromboembolism (TE) in patients with atrial fibrillation (AF) are largely derived from risk factors identified from trial cohorts. Thus, many potential risk factors have not been included. Methods: We refined the 2006 Birmingham/National Institute for Health and Clinical Excellence (NICE) stroke risk stratification schema into a risk factor-based approach by reclassifying and/or incorporating additional new risk factors where relevant. This schema was then compared with existing stroke risk stratification schema in a real-world cohort of patients with AF (n = 1,084) from the Euro Heart Survey for AF. Results: Risk categorization differed widely between the different schemes compared. Patients classified as high risk ranged from 10.2% with the Framingham schema to 75.7% with the Biramingham 2009 schema. T he classic CHADS(2), (Congestive heart failure, Hypertension, Age > 75, Diabetes, prior Stroke/transient isehemic attack) schema categorized the largest proportion (61.9%) into the intermediate-risk strata, whereas the Birmingham 2009 schema classified 15.1% into this category. The Birmingham 2009 schema classified only 9.2% as low risk, whereas the Framingham scheme categorized 48.3% as low risk. Calculated C-statistics suggested modest predictive value of all schema for TE. The Birmingham 2009 schema fared marginally better (C-statistic, 0.606) than CHADS(2). However, those classified as low risk by the Birmingham 2009 and NICE schema were truly low risk with no TE events recorded, whereas TE events occurred in 1.4% of low-risk CHADS(2) subjects. When expressed as a scoring system, the Birmingham 2009 schema (CHA(2)DS(2)-VASc acronym) showed an increase in TE rate with increasing scores (P value for trend = .003). Conclusion: Our novel, simple stroke risk stratification schema, based on a risk factor approach, provides some improvement in predictive value for TE over the CHADS(2) schema, with low event rates in low-risk subjects and the classification of only a small proportion of subjects into the in(intermediate-risk category. This schema could improve our approach to stroke risk stratification in patients with AF. CHEST 2010; 137(2):263-272
引用
收藏
页码:263 / 272
页数:10
相关论文
共 50 条
  • [1] A simple, new risk factor based approach to refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation: The Euro Heart Survey on atrial fibrillation
    Lip, G. Y. H.
    Nieuwlaat, R.
    Lane, D.
    Pisters, R.
    Crijns, H.
    EUROPEAN HEART JOURNAL, 2009, 30 : 979 - 979
  • [2] Validation of contemporary risk stratification schema for predicting stroke and thromboembolism in real world atrial fibrillation patients from the Euro Heart Survey on Atrial Fibrillation
    Nieuwlaat, R.
    Pisters, R.
    Lane, D. A.
    Crijns, H. J. G. M.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2009, 30 : 598 - 598
  • [3] Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation
    Aakre, Christopher A.
    McLeod, Christopher J.
    Cha, Stephen S.
    Tsang, Teresa S. M.
    Lip, Gregory Y. H.
    Gersh, Bernard J.
    STROKE, 2014, 45 (02) : 426 - 431
  • [4] Comparison of Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation
    Aakre, Christopher A.
    McLeod, Christopher J.
    Cha, Stephen S.
    Tsang, Teresa S.
    Lip, Gregory Y.
    Gersh, Bernard J.
    CIRCULATION, 2012, 126 (21)
  • [5] Assessing absolute stroke risk in patients with atrial fibrillation using a risk factor-based approach
    Lee, Christina J-Y
    Toft-Petersen, Anne Pernille
    Ozenne, Brice
    Phelps, Matthew
    Olesen, Jonas Bjerring
    Ellinor, Patrick T.
    Gislason, Gunnar
    Lip, Gregory Y. H.
    Torp-Pedersen, Christian
    Gerds, Thomas Alexander
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2021, 7 (F11) : F3 - F10
  • [6] "R" for "Renal" and for "Risk" Refining Risk Stratification for Stroke in Atrial Fibrillation
    Camm, A. John
    Savelieva, Irene
    CIRCULATION, 2013, 127 (02) : 169 - 171
  • [7] Is atrial fibrillation pattern a risk factor for thromboembolism in nonrheumatic atrial fibrillation?
    Qi, AZ
    Kerr, CR
    Connolly, SJ
    Wang, XH
    Boone, J
    Mooney, S
    Green, MS
    Klein, GJ
    Sheldon, R
    Talajic, M
    CIRCULATION, 1996, 94 (08) : 3891 - 3891
  • [8] RISK OF STROKE AND THROMBOEMBOLISM FOR HEART FAILURE WITH AND WITHOUT ATRIAL FIBRILLATION
    Kang, Si-Hyuck
    Kim, Joonghee
    Park, Jin-Joo
    Oh, Il-Young
    Yoon, Chang-Hwan
    Kim, Kyuseok
    Choi, Dong-Ju
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 901 - 901
  • [9] Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
    JoEllyn M. Abraham
    Stuart J. Connolly
    Heart Failure Reviews, 2014, 19 : 305 - 313
  • [10] Atrial fibrillation in heart failure: stroke risk stratification and anticoagulation
    Abraham, JoEllyn M.
    Connolly, Stuart J.
    HEART FAILURE REVIEWS, 2014, 19 (03) : 305 - 313